Question

Whole-exome sequencing (WES) is helping physicians diagnose a genetic condition that has defied diagnosis by traditional means. The implication here is that exons in the nuclear genome are sequenced in the hopes that, by comparison with the genomes of nonaffected individuals, a diagnosis might be revealed.
What are the strengths and weaknesses of this approach?

Accepted Answer

Step 1: Understand what Whole-Exome Sequencing (WES) entails. WES focuses on sequencing only the exons, which are the protein-coding regions of the nuclear genome. These regions represent about 1-2% of the entire genome but contain a large proportion of known disease-causing mutations. Step 2: Identify the strengths of WES. Since it targets exons, WES is cost-effective compared to whole-genome sequencing, allows for easier data analysis due to smaller data size, and is highly useful for detecting mutations that alter protein sequences, which are often responsible for genetic diseases. Step 3: Consider the weaknesses of WES. WES does not capture non-coding regions such as introns, regulatory elements, and intergenic regions, which can also harbor disease-causing variants. Additionally, WES may miss structural variants, copy number variations, and mutations in poorly captured or highly repetitive regions. Step 4: Reflect on the diagnostic implications. WES can provide a diagnosis when traditional methods fail by identifying rare or novel coding mutations, but it may not detect all genetic causes due to its limited scope, so negative results do not rule out a genetic condition. Step 5: Summarize by weighing the trade-offs. WES is a powerful tool for diagnosing many genetic disorders efficiently and economically, but its limitations mean that sometimes further testing, such as whole-genome sequencing or other molecular analyses, may be necessary for a comprehensive diagnosis.

비슷한 문제에 대한 검증된 영상 답변:

주요 개념

Whole-Exome Sequencing (WES)

Strengths of WES in Genetic Diagnosis

Limitations of WES